6
Participants
Start Date
February 28, 2014
Primary Completion Date
June 30, 2015
Study Completion Date
June 30, 2015
Lisdexamfetamine
Participants will be given either the study drug or placebo in tablet form. All participants will start with a 20 mg dose and will be titrated up to a 70 mg daily dose over 9 weeks. Participants between 12-18 years of age will be titrated in 10 mg increments and participants between 18-25 years of age in 10-20 mg increments.
UC Davis MIND Institute, Sacramento
Collaborators (1)
Shire
INDUSTRY
University of California, Davis
OTHER